Lower hypoglycemia rates with insulin degludec compared to insulin glargine: Data from a prospectively planned meta-analysis

作者
Jens Aberle,B Wilhelm,Bernard Zinman,Robert E. Ratner
出处
期刊:Experimental and Clinical Endocrinology & Diabetes [Thieme Medical Publishers (Germany)]
卷期号:121 (03)
标识
DOI:10.1055/s-0033-1336725
摘要

Introducution: Insulin degludec (IDeg) is a new basal insulin that forms soluble multihexamers after sc injection. Ideg has long and stable glucose-lowering effect. Methods: The objective of this pre-specified analysis was to compare the rate of hypoglycemia with IDeg vs. IGlar across trials. Hypoglycemia was defined as follows: self-reported confirmed hypoglycaemia = PG< 56 mg/dL or severe hypoglycemia (requiring assistance) nocturnal confirmed hypoglycaemia = 00:01 – 05:59 incl. Rates were analyzed with a negative binomial regression model on patient level data. In the analysis all open-labeled, randomized, treat-to-target phase 3a trials of 26 or 52 weeks were included in which once-daily IDeg (n = 2899) was compared to IGlar (n = 1431) in T1DM (2 trials) and T2DM (5 trials). Results: IDeg showed statistically significantly lower rates for nocturnal hypoglycemia compared to IGlar for the pooled population of type 1 and 2 diabetes and for overall hypoglycemia in T2DM (Table). More pronounced benefits of Ideg could be revealed in analyses of the maintenance period (stable glycemia and insulin dose [obtained from 16 weeks onward]). Additional heterogeneity analysis revealed significantly less risk of severe hypoglycemia with IDeg vs. IGlar in insulinnaïve T2DM (rate ratio 0.14 [0.03; 0.70] 95% CI). Conclusion: This meta-analysis showed significantly lower rates especially for nocturnal hypoglycemia than IGlar at similar levels of A1C for Ideg compared to Iglar. Therefore treatment with Ideg may provide clinical advantages for patients. Table 1: Metaanalysis of confirmed hypoglycemia Rate overall hypoglycemia (Ideg/Iglar) Rate nocturnal hypoglycemia (Ideg/Iglar) Complete study Maintenance period Complete study Maintenance period T2DM 0.83 [0.74; 0.94]* 0.75 [0.66; 0.87]* 0.68 [0.57; 0.82]* 0.62 [0.49; 0.78]* T2DM-insulinnaive 0.83 [0.70; 0.98]* 0.72 [0.58; 0.88]* 0.64 [0.48; 0.86]* 0.51 [0.36; 0.72]* T1DM 1.10 [0.96; 1.26] 1.02 [0.88; 1.19] 0.83 [0.69; 1.00]* 0.75 [0.60; 0.94]* T1DM +T2DM 0.91 [0.83; 0.99]* 0.84 [0.75; 0.93]* 0.74 [0.65; 0.85]* 0.68 [0.58; 0.80]*

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
心脏完成签到 ,获得积分20
刚刚
昵称发布了新的文献求助30
刚刚
刚刚
1秒前
星星完成签到,获得积分10
1秒前
虚幻姿发布了新的文献求助10
1秒前
1秒前
细心的抽屉完成签到,获得积分20
2秒前
Hello应助Shiniruo采纳,获得10
2秒前
CodeCraft应助腼腆的冰淇淋采纳,获得10
2秒前
2秒前
桐桐应助Yxs采纳,获得10
2秒前
zzb完成签到,获得积分10
3秒前
聪明山兰完成签到,获得积分10
3秒前
keke完成签到,获得积分10
3秒前
蛋蛋完成签到,获得积分10
3秒前
学术文献互助应助earlshu采纳,获得100
3秒前
科研通AI6.2应助wyq采纳,获得10
4秒前
4秒前
5秒前
Hello应助amberzyc采纳,获得10
5秒前
尊敬的冥完成签到,获得积分10
5秒前
生动的慕卉完成签到,获得积分10
5秒前
果称完成签到,获得积分10
5秒前
5秒前
独特忆灵完成签到,获得积分10
7秒前
111发布了新的文献求助10
7秒前
顺其自然完成签到,获得积分10
7秒前
科研通AI2S应助keke采纳,获得10
7秒前
小曦瓜发布了新的文献求助10
7秒前
六六发布了新的文献求助10
8秒前
8秒前
芋泥丸丸完成签到,获得积分10
8秒前
8秒前
未来完成签到 ,获得积分10
8秒前
8秒前
听话的代芙完成签到 ,获得积分10
8秒前
亚齐发布了新的文献求助20
8秒前
9秒前
Hello应助刘杭采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
An Introduction to Foreign Language Learning and Teaching 750
The Oxford Handbook of Digital Classical Studies 550
China Pluperfect I: Epistemology of Past and Outside in Chinese Art 520
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
The fast track to determining transfer functions of linear circuits: The student guide 500
The Analytical and Numerical Solution of Electric and Magnetic Fields 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7621015
求助须知:如何正确求助?哪些是违规求助? 9195931
关于积分的说明 19710949
捐赠科研通 7192398
什么是DOI,文献DOI怎么找? 3272628
关于科研通互助平台的介绍 2435199
邀请新用户注册赠送积分活动 2267793